Please use this identifier to cite or link to this item: https://repositorio.udes.edu.co/handle/001/3281
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGómez Arbeláez, Diegospa
dc.contributor.authorLahera, Vicentespa
dc.contributor.authorOubiña, Maria del Pilarspa
dc.contributor.authorValero Muñoz, Mariaspa
dc.contributor.authorDe las Heras, Nataliaspa
dc.contributor.authorRodríguez, Yudyspa
dc.contributor.authorGarcía, Ronald G.spa
dc.contributor.authorCamacho López, Paul Anthonyspa
dc.contributor.authorLópez Jaramillo, Patriciospa
dc.date.accessioned2019-07-06T15:22:30Zspa
dc.date.available2019-07-06T15:22:30Zspa
dc.date.issued2013-01spa
dc.identifier.isbn0962-9351spa
dc.identifier.issn1466-1861spa
dc.identifier.urihttp://repositorio.udes.edu.co/handle/001/3281spa
dc.description7 p.spa
dc.description.abstractBackground. Garlic (Allium sativum) has been shown to have important benefits in individuals at high cardiovascular risk. The aim of the present study was to evaluate the effects of the administration of aged garlic extract (AGE) on the risk factors that constitute the cluster of metabolic syndrome (MS). Methods and Design. Double-blind, crossover, randomized, placebo-controlled clinical trial to assess the effect of 1.2 g/day of AGE (Kyolic), for 24 weeks of treatment (12 weeks of AGE and 12 weeks of placebo), on subjects with MS. Results. The administration of AGE increased the plasma levels of adiponectin (𝑃 = 0.027). No serious side effects associated with the intervention were reported. Conclusion. The present results have shown for the first time that the administration of AGE for 12 weeks increased plasma adiponectin levels in patients with MS. This suggests that AGE might be a useful, novel, nonpharmacological therapeutic intervention to increase adiponectin and to prevent cardiovascular (CV) complications in individuals with MS.eng
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.relation.ispartofMediators of Inflammationeng
dc.rightsDerechos Reservados - Universidad de Santander, 2013spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.sourcehttps://www.hindawi.com/journals/mi/2013/285795/eng
dc.titleAged garlic extract improves adiponectin levels in subjects with metabolic syndrome : A double-blind, placebo-controlled, randomized, crossover studyeng
dc.typeArtículo de revistaspa
dc.identifier.doi10.1155/2013/285795spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)spa
dc.subject.proposalAged garliceng
dc.subject.proposalMetabolic syndromeeng
dc.subject.proposalAdiponectineng
dc.subject.proposalplacebo-controlledeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.type.contentTextspa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
Appears in Collections:DCABA. Artículos de Investigación



This item is licensed under a Creative Commons License Creative Commons